Q15JF5 AF NFT

Validoxylamine A glucosyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifmo74fnirs6hx5ryod7h5tre4klrbuq6ezuvo4ufbidewepdckhi/metadata.json
IPFS of structure file: 
bafybeicfu3u6xlzw73b23b5z3eohwa6mbfjsrzf7eeji4oc7h72og5cc3y/AF-Q15JF5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x619F51Fb686eB178E60C23E8610260c3C69601D6
First NFT owner address (bech32): 
genesis1vx04r7mgd6ch3esvy05xzqnqc0rfvqwk6kq4d4
Current NFT ID #497023 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
497023
Accession (UniProt):
Q15JF5
Name::
Validoxylamine A glucosyltransferase
Experimental Method:
Predicted structure
Sequence source:
STREPTOMYCES HYGROSCOPICUS SUBSP. LIMONEUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q15JF5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q15JF5|VLDK_STRHL Validoxylamine A glucosyltransferase OS=Streptomyces hygroscopicus subsp. limoneus OX=264445 GN=vldK PE=3 SV=1 MEGVDIPGRPSPWRVCVTRPQVHPINAKVAPMPGATSHVPLLSVVIPTYNRDALLDRTLGTLARQTTAPEDFEVVVSDDGSTDTTRDVVRSYEDRLRIKYVFQEDLGYRVASARNGGARLASAPLLAFLDTGVLAGPQYVQSVLAAHAGPAPAKVVLGCCYGYDPRNPHPELHSLVEEFPPEEAVRRVGDAPWFQDMRLPEFTAVDFDLSRMHMPWLWFWTLNVSLPAADFWRVGGFDEDFTGWGGEDIELGYRLHAHGIPMTVSRESWGIEAPHERTHEANVSSLMLNCDRFVRKHPSLLPELFWAVTNRGIFGSVETERLRFEEWASQARGQQVLDEIAIGLDTLPPSQHTQRVAVFGSGTEGLPTAPRQNVELFLCDYDEGVLARQESRDDGAVSTWHLSGLRTPWPDQHFDLVIITSRMDGPRQAWGEAFTKEAHRIASSVVEPSLSGD